Cited by 1,043Neurological diseases and metabolismParkinson's Disease Mechanisms and TreatmentsTrace Elements in Health

The DOI matches its Crossref record.

ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E, LEES, A. J., JENNER, P., MARSDEN, C. D.·1991·Brain

DOI 10.1093/brain/114.4.1953

Open this paper in CoChat — free account

Abstract

Levels of iron, copper, zinc and manganese were measured by inductively coupled plasma spectroscopy in frozen postmortem brain tissue from patients with Parkinson's disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy with strionigral degeneration (MSA), and Huntington's disease (HD) compared with control subjects. Total iron levels were found to be elevated in the areas of basal ganglia showing pathological change in these disorders. In particular, total iron content was increased in substantia nigra in PD, PSP and MSA, but not in HD. Total iron levels in the striatum (putamen and/or caudate nucleus) were increased in PSP, MSA and HD but not in PD. Total iron levels were decreased in the globus pallidus in PD. There were no consistent alterations of manganese levels in basal ganglia structures in any of the diseases studied. Copper levels were decreased in the substantia nigra in PD, and in the cerebellum in PSP, and were elevated in the putamen and possibly substantia nigra in HD. Zinc levels were only increased in PD, in substantia nigra and in caudate nucleus and lateral putamen. Levels of the iron binding protein ferritin were measured in the same patient groups using a radio-immunoassay technique. Increased iron levels in basal ganglia were generally associated with normal or elevated levels of ferritin immunoreactivity, for example, the substantia nigra in PSP and possibly MSA, and in putamen in MSA. The exception was PD where there was a generalized reduction in brain ferritin immunoreactivity, even in the substantia nigra. An increase in total iron content appears to be a response to neurodegeneration in affected basal ganglia regions in a number of movement disorders. However, only in PD was there an increased total iron level, decreased ferritin content, decreased copper content, and an increased zinc concentration in substantia nigra. These findings suggest an alteration of iron handling in the substantia nigra in PD. Depending on the form in which the excess iron load exists in nigra in PD, it may contribute to the neurodegenerative process.

Integrity signals

Registry

Crossref · 10.1093/brain/114.4.1953

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 401–500 of 1,000

Brain trace elements and aging
Hebbrecht, G., Maenhaut, W., & Reuck, J. D. (1999) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/s0168-583x(98)00938-0 · Cited by 53
Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms
Peralta, C., Strafella, A. P., van Eimeren, T., Ceravolo, R., Seppi, K., Kaasinen, V., Arena, J., Lehéricy, S., & the International Parkinson Movement Disorders Society‐Neuroimaging Study Group (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13354 · Cited by 53
Striosomes control dopamine via dual pathways paralleling canonical basal ganglia circuits
Lazaridis, I., Crittenden, J. R., Ahn, G., Hirokane, K., Wickersham, I. R., Yoshida, T., Mahar, A., Skara, V., Loftus, J., Parvataneni, K., et al. (2024) · Current Biology · doi:10.1016/j.cub.2024.09.070 · Cited by 58
Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: An in vivo microdialysis study
Matteo, V. D., Pierucci, M., Giovanni, G. D., Santo, A. D., Poggi, A., Benigno, A., & Esposito, E. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.013 · Cited by 53
Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's disease.
Iczkiewicz, J., Jackson, M., Smith, L. A., Rose, S., & Jenner, P. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.036 · Cited by 60
Self-citation
Depletion of Intracellular Glutathione Increases Susceptibility to Nitric Oxide in Mesencephalic Dopaminergic Neurons
Ibi, M., Sawada, H., Kume, T., Katsuki, H., Kaneko, S., Shimohama, S., & Akaike, A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.731696.x · Cited by 53
Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
Peterson, A. C., & Li, C. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00127 · Cited by 58
Anatomy of the Substantia Nigra and Subthalamic Nucleus on MR Imaging
Massey, L. A., & Yousry, T. A. (2009) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2009.10.001 · Cited by 57
Ferritin and ferritin isoforms II: Protection against uncontrolled cellular proliferation, oxidative damage and inflammatory processes
Koorts, A. M., & Viljoen, M. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701422575 · Cited by 51
Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy
Kuiper, M. A., Mulder, C., van Kamp, G. J., Scheltens, P., & Wolters, E. C. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260965 · Cited by 52
L‐DOPA Does Not Enhance Hydroxyl Radical Formation in the Nigrostriatal Dopamine System of Rats with a Unilateral 6‐Hydroxydopamine Lesion
Camp, D. M., Loeffler, D. A., & LeWitt, P. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741229.x · Cited by 52
Protective effect of serotonin on 6-hydroxydopamine- and dopamine-induced oxidative damage of brain mitochondria and synaptosomes and PC12 cells
Park, J. W., Youn, Y. C., Kwon, O. S., Jang, Y.-Y., Han, E. S., & Lee, C. S. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00072-9 · Cited by 52
Characterization of age-related microstructural changes in locus coeruleus and substantia nigra pars compacta
Langley, J. A., Hussain, S., Flores, J. J., Bennett, I. J., & Hu, X. P. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.11.016 · Cited by 49
Overdosing on iron: Elevated iron and degenerative brain disorders
D’Mello, S. R., & Kindy, M. S. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220953065 · Cited by 49
Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease
Khan, S. S., Jaimon, E., Lin, Y.-E., Nikoloff, J., Tonelli, F., Alessi, D. R., & Pfeffer, S. R. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402206121 · Cited by 61
“Low brain ferritin has been previously reported in the Substantia nigra, caudate putamen, globus pallidus, cerebral cortex, and cerebellum in human PD (42, 43), and mouse brains deficient in ferritin heavy chain show evidence of oxidative stress (44).”
Background
Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage
Du, G., Wang, E., Sica, C. T., Chen, H., Jesus, S. D., Lewis, M. M., Kong, L., Connor, J. R., Mailman, R. B., & Huang, X. (2022) · Movement Disorders · doi:10.1002/mds.29062 · Cited by 51
Internal structures of the globus pallidus in patients with Parkinson’s disease: evaluation with quantitative susceptibility mapping (QSM)
Ide, S., Kakeda, S., Ueda, I., Watanabe, K., Murakami, Y., Moriya, J., Ogasawara, A., Futatsuya, K., Satô, T., Ohnari, N., et al. (2014) · European Radiology · doi:10.1007/s00330-014-3472-7 · Cited by 49
Iron and neurodegeneration
Olanow, C. W., & Youdim, M. B. H. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50006-0 · Cited by 50
The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders
Wong, B. X. W., & Duce, J. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00081 · Cited by 50
PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper
Aboud, A. A., Tidball, A. M., Kumar, K. K., Neely, M. D., Han, B., Ess, K. C., Hong, C. C., Erikson, K. M., Hedera, P., & Bowman, A. B. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.002 · Cited by 50
Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson’s disease
Raichur, A. M., Vali, S., & Gorin, F. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.052 · Cited by 49
Pathogenesis and preclinical course of Parkinson’s disease
Foley, P., & Riederer, P. F. (1999) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6360-3_2 · Cited by 50
A review of vitamin D and Parkinson's disease
Peterson, A. L. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.02.012 · Cited by 48
Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry
Nürnberger, L., Gracien, R., Hok, P., Hof, S., Rüb, U., Steinmetz, H., Hilker, R., Klein, J. C., Deichmann, R., & Baudrexel, S. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.12.025 · Cited by 48
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias
Hsu, Y., Du, A., Schuff, N. W., & Weiner, M. W. (2001) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870101400308 · Cited by 46
Manganese concentration in rat brain: manganese transport from the peripheral tissues
Takeda, A., Sawashita, J., & Okada, S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00006-8 · Cited by 48
Neuroprotective Effect of Acute and Chronic Administration of Copper (II) Sulfate against MPP+ Neurotoxicity in Mice
Alcaraz-Zubeldia, M., Rojas, P., Boll, C., & Rı́os, C. (2001) · Neurochemical Research · doi:10.1023/a:1007680616056 · Cited by 48
Knocking out alpha-synuclein in melanoma cells dysregulates cellular iron metabolism and suppresses tumor growth
Shekoohi, S., Rajasekaran, S., Patel, D., Yang, S., Liu, W., Huang, S., Yu, X., & Witt, S. N. (2021) · Scientific Reports · doi:10.1038/s41598-021-84443-y · Cited by 49
Clinical MRI for iron detection in Parkinson's disease
Rossi, M. E., Ruottinen, H., Soimakallio, S., Elovaara, I., & Dastidar, P. (2013) · Clinical Imaging · doi:10.1016/j.clinimag.2013.02.001 · Cited by 47
The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity
Rinaldi, D. E., Corradi, G. R., Cuesta, L. M., Adamo, H. P., & Pinto, F. D. T. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.04.008 · Cited by 47
Alzheimer’s Disease, Neuroprotection, and CNS Immunosenescence
Streit, W. J., & Xue, Q. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00138 · Cited by 52
Brain Iron and Zinc Contents of German Patients with Alzheimer Disease
Andrási, E., Farkas, E. B., Gawlik, D., Rösick, U., & Brätter, P. (2000) · Journal of Alzheimer s Disease · doi:10.3233/jad-2000-2103 · Cited by 47
From zinc homeostasis to disease progression: Unveiling the neurodegenerative puzzle
Fan, Y., Wu, T.-Y., Zhao, L., Jia, R., Hang, R., Hou, W., & Wang, Z. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107039 · Cited by 49
The Role of Trace Metallic Elements in Neurodegenerative Disorders: Quantitative Analysis Using XRF and XANES Spectroscopy
Ide‐Ektessabi, A., & Rabionet, M. (2005) · Analytical Sciences · doi:10.2116/analsci.21.885 · Cited by 46
Alpha-synuclein and iron: two keys unlocking Parkinson’s disease
Lingor, P., Carboni, E., & Koch, J. C. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1695-x · Cited by 48
Iron in neurodegenerative disorders: being in the wrong place at the wrong time?
Apostolakis, S., & Kypraiou, A.-M. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0020 · Cited by 47
Dietary intake of iron, zinc, copper, and risk of Parkinson’s disease: a meta-analysis
Cheng, P., Jia, Y., Huang, W. C., Bai, S., Zhu, X., Qi, Z., Shao, W., & Xie, P. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2349-0 · Cited by 46
Magnetic investigations of human mesencephalic neuromelanin
Bolzoni, F., Giraudo, S., Lopiano, L., Bergamasco, B., Fasano, M., & Crippa, P. R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00099-0 · Cited by 46
Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds
Zhong, G., Wang, X., Li, J., Xie, Z., Wu, Q., Chen, J., Wang, Y., Chen, Z., Cao, X., Li, T., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231103085859 · Cited by 49
The secret life of extracellular vesicles in metal homeostasis and neurodegeneration
Bellingham, S. A., Guo, B. B., & Hill, A. F. (2015) · Biology of the Cell · doi:10.1111/boc.201500030 · Cited by 45
The Ferroxidase Hephaestin But Not Amyloid Precursor Protein is Required for Ferroportin-Supported Iron Efflux in Primary Hippocampal Neurons
Ji, C., Steimle, B. L., Bailey, D. K., & Kosman, D. J. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0568-z · Cited by 50
Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease
Sun, Y., Pham, A. N., Hare, D. J., & Waite, T. D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00859 · Cited by 47
Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein
Teng, Y., Zhao, J., Ding, L., Ding, Y., & Zhou, P. (2019) · Molecules · doi:10.3390/molecules24162940 · Cited by 47
Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia
Scholefield, M., Church, S. J., Xu, J., Patassini, S., Roncaroli, F., Hooper, N. M., Unwin, R. D., & Cooper, G. J. S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.641222 · Cited by 44
Formation of DNA Adducts and Oxidative Base Damage by Copper Mediated Oxidation of Dopamine and 6-Hydroxydopamine
Lévay, G. I., Ye, Q., & Bodell, W. J. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6560 · Cited by 45
Dopamine neurotoxicity: age-dependent behavioral and histological effects
Cantuti‐Castelvetri, I., Shukitt‐Hale, B., & Joseph, J. A. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00186-0 · Cited by 45
Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex
Sastry, S., & Arendash, G. W. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00618-f · Cited by 45
Abnormal magnetic resonance imaging T2 relaxation time asymmetries in Tourette's Syndrome
Peterson, B. S., Cohen, D. J., Leckman, J. F., Gore, J. C., & Riddle, M. A. (1994) · Psychiatry Research · doi:10.1016/0925-4927(94)90015-9 · Cited by 44
Oxidative events in neuronal and glial cell-enriched fractions of rat cerebral cortex
Café, C., Torri, C., Bertorelli, L., Tartara, F., Tancioni, F., Gaetani, P., y Baena, R. R., & Marzatico, F. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00086-d · Cited by 45
Restoration of metal homeostasis: a potential strategy against neurodegenerative diseases
Zhang, Y., Li, X., Ren, K., Peng, J., & Luo, X. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101931 · Cited by 46
Alpha-synuclein: relating metals to structure, function and inhibition
McDowall, J., & Brown, D. R. (2016) · Metallomics · doi:10.1039/c6mt00026f · Cited by 44
In vivo stimulation-induced release of manganese in rat amygdala
Takeda, A., Ishiwatari, S., & Okada, S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00881-6 · Cited by 44
Neuroimaging for Lewy body disease: Is the in vivo molecular imaging of α-synuclein neuropathology required and feasible?
Vernon, A. C., Ballard, C. G., & Modo, M. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.05.006 · Cited by 44
MR relaxometry in Huntington's disease: Correlation between imaging, genetic and clinical parameters
Vymazal, J., Klempíř, J., Jech, R., Židovská, J., Syka, M., Růžička, E., & Roth, J. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.05.018 · Cited by 43
Alpha-Synuclein Regulates Neuronal Levels of Manganese and Calcium
Dučić, T., Carboni, E., Lai, B. C. H., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00093 · Cited by 43
Alpha‐synuclein and its role in metal binding: Relevance to Parkinson's disease
Wright, J. A., & Brown, D. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21461 · Cited by 44
Etiology of Parkinson's Disease
Stoessl, A. J. (1999) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100000032 · Cited by 43
Parkinson's Disease: Past, Present, and Future
Kopin, I. J. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.39 · Cited by 43
MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease
Jurgens, C. K., Jasinschi, R., Ekin, A., Witjes‐Ané, M. W., van der Grond, J., Middelkoop, H. A. M., & Roos, R. A. C. (2010) · PLoS Currents · doi:10.1371/currents.rrn1173 · Cited by 42
Wnt3a protects SH-SY5Y cells against 6-hydroxydopamine toxicity by restoration of mitochondria function
Wei, L., Ding, L., Mo, M., Lei, M., Zhang, L., Chen, K., & Xu, P. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0033-1 · Cited by 43
Parkinson's disease: pathological mechanisms and actions of piribedil
Jenner, P. G. (1992) · Journal of Neurology · doi:10.1007/bf00819559 · Cited by 42
Self-citation
Ferritin oxidation and proteasomal degradation: Protection by antioxidants
Voß, P., Horáková, Ľ., Jakstadt, M., Kiekebusch, D., & Grune, T. (2006) · Free Radical Research · doi:10.1080/10715760500419357 · Cited by 41
An Unusual Decarboxylative Maillard Reaction between l -DOPA and d -Glucose under Biomimetic Conditions: Factors Governing Competition with Pictet−Spengler Condensation
Manini, P., d'Ischi, M., & Prota, G. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo010078d · Cited by 42
Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits
Fredriksson, A., Schröder, N., Eriksson, P. O., Izquierdo, I., & Archer, T. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00028-6 · Cited by 42
Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease
Berggren, K. L., Chen, J., Fox, J. A., Miller, J., Dodds, L., Dugas, B., Vargas, L., Lothian, A., McAllum, E., Volitakis, I., et al. (2015) · Redox Biology · doi:10.1016/j.redox.2015.02.002 · Cited by 42
Brain Iron Deposition and Sequence Characteristics in Parkinsonism
Rossi, M. E., Ruottinen, H., Elovaara, I., Ryymin, P., Soimakallio, S., Eskola, H. J., & Dastidar, P. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181ec9c96 · Cited by 41
Neuroprotective Effect of a New 7,8-Dihydroxycoumarin-Based Fe 2+ /Cu 2+ Chelator in Cell and Animal Models of Parkinson’s Disease
Aguirre, P., García‐Beltrán, O., Tapia, V., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00309 · Cited by 41
Shared perturbations in the metallome and metabolome of Alzheimer’s, Parkinson’s, Huntington’s, and dementia with Lewy bodies: A systematic review
Scholefield, M., Unwin, R. D., & Cooper, G. J. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101152 · Cited by 39
A novel NIR fluorescent probe for copper( ii ) imaging in Parkinson's disease mouse brain
Chen, J., Luo, R., Li, S., Shao, J., Wang, T., Xie, S., Xu, L., You, Q., Feng, S., & Feng, G. (2024) · Chemical Science · doi:10.1039/d4sc03445g · Cited by 42
Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators
Workman, D. G., Tsatsanis, A., Lewis, F. W., Boyle, J. P., Mousadoust, M., Hettiarachchi, N. T., Hunter, M., Peers, C., Tétard, D., & Duce, J. A. (2015) · Metallomics · doi:10.1039/c4mt00326h · Cited by 40
A novel approach to quantify different iron forms in ex-vivo human brain tissue
Kumar, P., Bulk, M., WEBB, A. G., van der Weerd, L., Oosterkamp, T. H., Huber, M., & Bossoni, L. (2016) · Scientific Reports · doi:10.1038/srep38916 · Cited by 40
Acute exposure to chlorpyrifos caused NADPH oxidase mediated oxidative stress and neurotoxicity in a striatal cell model of Huntington’s disease
Dominah, G. A., McMinimy, R. A., Kallon, S., et al. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.004 · Cited by 40
Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease
He, N., Langley, J. A., Huddleston, D. E., Chen, S., Huang, P., Ling, H., Yan, F., & Hu, X. P. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102391 · Cited by 40
The effects of 6-hydroxydopamine and oxidative stress on the level of brain metallothionein
Shiraga, H., Pfeiffer, R. F., & Ebadi, M. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90104-d · Cited by 40
Untitled work
Goodrum (2000) · doi:10.1002/(sici)1097-4547(20000215)59:4
The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson’s disease: Correlation with 18F-flurodeoxyglucose positron-emission tomography
Yoon, R. G., Kim, S. J., Kim, H. S., et al. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.046 · Cited by 39
The rich electrochemistry and redox reactions of the copper sites in the cellular prion protein
Zhou, F., & Millhauser, G. L. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.04.035 · Cited by 40
Cholesterol: A Two-Edged Sword in Brain Aging
Joseph, J. A., Villalobos-Molinas, R., Denisova, N. A., Erat, S., & Strain, J. G. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00376-0 · Cited by 38
Activation of iron handling system within the gerbil hippocampus after cerebral ischemia
Ishimaru, H., Ishikawa, K., Ohe, Y., Takahashi, A., Tatemoto, K., & Maruyama, Y. (1996) · Brain Research · doi:10.1016/0006-8993(96)00294-6 · Cited by 39
Absence of Mutations in Superoxide Dismutase and Catalase Genes in Patients With Parkinson's Disease
Parboosingh, J. S., Rousseau, M., Rogan, F., Amit, Z., Chertkow, H. M., Johnson, W. G., Manganaro, F., Schipper, H., Curran, T. J., Stoessl, A. J., et al. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540360038013 · Cited by 38
Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration
McNaught, K. S. P., Thull, U., Carrupt, P., et al. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00091-3 · Cited by 38
Self-citation
Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions
Kumar, V., Singh, B. K., Chauhan, A. K., Singh, D., Patel, D. K., & Singh, C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9137-y · Cited by 37
“Increased accumulation of heavy metals, such as iron (Fe), zinc (Zn) and manganese (Mg) in the brain of PD patients emphasizes their possible role in PD [3].”
Background
The Central Role of Biometals Maintains Oxidative Balance in the Context of Metabolic and Neurodegenerative Disorders
Pokusa, M., & Trancikova, A. K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8210734 · Cited by 37
Synaptic zinc contributes to motor and cognitive deficits in 6-hydroxydopamine mouse models of Parkinson's disease
Sikora, J., Kieffer, B. L., Paoletti, P., & Ouagazzal, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104681 · Cited by 37
Progressive supranuclear palsy: Clinical presentation and rehabilitation of two patients
Sosner, J., Wall, G. C., & Sznajder, J. (1993) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/0003-9993(93)90120-y · Cited by 37
Voxel‐Based Statistical Analysis of Fractional Anisotropy and Mean Diffusivity in Patients with Unilateral Temporal Lobe Epilepsy of Unknown Cause
Keller, S. S., Ahrens, T., Mohammadi, S., Gerdes, J. S., Möddel, G., Kellinghaus, C., Kugel, H., Weber, B., Ringelstein, E. B., & Deppe, M. (2011) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2011.00673.x · Cited by 39
Investigation of the effects of copper ions on protein aggregation using a model system
Capanni, C., Luigi Messori, A., Orioli, P., Chiti, F., Stefani, M., Ramponi, G., Taddei, N., & Gabrielli, S. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3447-3 · Cited by 40
Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?
Leathem, A., Ortíz, T., Dennis, J. M., & Witting, P. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136923 · Cited by 36
Multiple System Atrophy: Genetic or Epigenetic?
Sturm, E., & Stefanova, N. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.277 · Cited by 38
α-synuclein-lanthanide metal ions interaction: binding sites, conformation and fibrillation
Bai, J. Q. A., Zhang, Z., Liu, M., & Li, C. (2015) · BMC Biophysics · doi:10.1186/s13628-016-0026-1 · Cited by 37
Efficient and biologically relevant consensus strategy for Parkinson’s disease gene prioritization
Cruz‐Monteagudo, M., Borges, F., Paz‐y‐Miño, C., Cordeiro, M. N. D. S., Rebelo, I., Pérez‐Castillo, Y., Helguera, A. M., Sánchez‐Rodríguez, A., & Tejera, E. (2016) · BMC Medical Genomics · doi:10.1186/s12920-016-0173-x · Cited by 37
Structural and functional quantitative susceptibility mapping from standard fMRI studies
Sun, H., Seres, P., & Wilman, A. H. (2016) · NMR in Biomedicine · doi:10.1002/nbm.3619 · Cited by 35
High-resolution QSM for functional and structural depiction of subthalamic nuclei in DBS presurgical mapping
Dimov, A., Gupta, A. K., Kopell, B. H., et al. (2018) · Journal of neurosurgery · doi:10.3171/2018.3.jns172145 · Cited by 36
Heterozygous huntingtin promotes cadmium neurotoxicity and neurodegeneration in striatal cells via altered metal transport and protein kinase C delta dependent oxidative stress and apoptosis signaling mechanisms
Kwakye, G. F., Jiménez, J. A., Thomas, M. G., et al. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.10.012 · Cited by 36
Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease
Zaidi, F. K., & Deep, S. (2020) · Biochemical Journal · doi:10.1042/bcj20190705 · Cited by 37
Metal Imbalance in Neurodegenerative Diseases with a Specific Concern to the Brain of Multiple Sclerosis Patients
Dalès, J.-P., & Desplat‐Jégo, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239105 · Cited by 36
Environmental Factors and Parkinson's Disease: A Case-Control Study in Belgrade, Serbia
Vlajinac, H., Grujičić, S. Š., Maksimovic, J. M., Marinković, J., Dzoljic, E. D., Ratkov, I., & Kostić, V. (2010) · International Journal of Neuroscience · doi:10.3109/00207451003668374 · Cited by 36
Mucuna pruriens seeds in treatment of Parkinson’s disease: pharmacological review
Kasture, S. B., Mohan, M., & Kasture, V. S. (2013) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-013-0126-2 · Cited by 36
Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration
Kaur, D., Rajagopalan, S., Chinta, S., Kumar, J., Di Monte, D., Cherny, R. A., & Andersen, J. K. (2007) · Brain Research · doi:10.1016/j.brainres.2006.03.006 · Cited by 36
Challenges and complexities of α-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson’s disease
Hegde, M. L., & Rao, K. S. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.015 · Cited by 37

Authors: DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D.
Affiliations: King's College London (GB)
Inserm (FR)
Parkinson's UK (GB)
Corresponding author: JENNER, P.
ORCID: DEXTER, D. T.
DANIEL, S. E
LEES, A. J.
JENNER, P.
Venue: Brain
Publisher: Oxford University Press (OUP)
Published: 1991
Volume: 114
Issue: 4
Pages: 1953-1975
ISSN: 0006-8950 (ISSN-L)
1460-2156
DOI: 10.1093/brain/114.4.1953
OpenAlex: W2123913108
Cited by: 1,043
References: 0
Citations by year: 2026: 18 · 2025: 29 · 2024: 47 · 2023: 28 · 2022: 37 · 2021: 43 · 2020: 36 · 2019: 38 · 2018: 30 · 2017: 45 · 2016: 56 · 2015: 45 · 2014: 41 · 2013: 44 · 2012: 32
FWCI: 12.57
Type: journal article
Language: en
Open access: closed
Locations: Brain (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Royal Society
Topics: Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Keywords: Parkinson's disease, progressive supranuclear palsy, multiple system atrophy, Huntington's disease, basal ganglia, iron, ferritin, copper, zinc, manganese, substantia nigra, striatum, globus pallidus, neurodegeneration, trace metals, iron overload
MeSH terms: Aging, Atrophy, Basal Ganglia Diseases, Brain, Brain Diseases, Ferritins, Humans, Huntington Disease, Iron, Metals, Parkinson Disease, Radioimmunoassay, Reference Values, Supranuclear Palsy, Progressive, Trace Elements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks